2C-B-FLY
Sign in to save2C-B-FLY is a psychedelic and designer drug of the phenethylamine, 2C, and FLY families. It was first described in 1995 by Aaron Monte, Professor of Chemistry at UW-La Crosse.
Article
16 sectionsContents
- Use and effects
- Toxicity
- Interactions
- Pharmacology
- Pharmacodynamics
- Chemistry
- Analogues and derivatives
- History
- Society and culture
- Legal status
- Canada
- Finland
- United States
- See also
- References
- External links
2C-B-FLY is a psychedelic and designer drug of the phenethylamine, 2C, and FLY families. It was first described in 1995 by Aaron Monte, Professor of Chemistry at UW-La Crosse.
==Use and effects== 2C-B-FLY was not included nor mentioned in Alexander Shulgin's 1991 book PiHKAL (Phenethylamines I Have Known and Loved). In his subsequent 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds however, he listed 2C-B-FLY's dose as 2.5 to 10mg orally. On the other hand, other sources give 2C-B-FLY's typical dose range as 10 to 20mg orally. The duration of 2C-B-FLY is said to be 6 to 10hours but up to 20hours. The effects of 2C-B-FLY have been reported to include euphoria, enhanced interpersonal communication, improved mood, closed- and open-eye visuals such as brightening of colors and visual hallucinations, feelings of insight, stimulation, tactile enhancement, sexual enhancement, and altered time perception. Other reported effects include pupil dilation, muscle twitching, restlessness, tachycardia, and body temperature changes.